SGAM
Smith Group Asset Management’s Edwards Lifesciences EW Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-318,638
| Closed | -$22M | – | 320 |
|
|
2020
Q2 | $22M | Buy |
318,638
+197,015
| +162% | +$13.6M | 1.21% | 24 |
|
|
2020
Q1 | $23M | Sell |
121,623
-10,712
| -8% | -$2.02M | 1.25% | 24 |
|
|
2019
Q4 | $30.9M | Buy |
+132,335
| New | +$30.9M | 1.29% | 21 |
|
|
2017
Q4 | – | Sell |
-244,360
| Closed | -$26.7M | – | 447 |
|
|
2017
Q3 | $26.7M | Sell |
244,360
-58,800
| -19% | -$6.43M | 0.89% | 36 |
|
|
2017
Q2 | $35.8M | Sell |
303,160
-108,900
| -26% | -$12.9M | 1.1% | 31 |
|
|
2017
Q1 | $38.8M | Sell |
412,060
-33,800
| -8% | -$3.18M | 1.12% | 30 |
|
|
2016
Q4 | $41.8M | Sell |
445,860
-6,160
| -1% | -$577K | 1.22% | 26 |
|
|
2016
Q3 | $54.5M | Sell |
452,020
-3,970
| -0.9% | -$479K | 1.6% | 17 |
|
|
2016
Q2 | $45.5M | Sell |
455,990
-71,080
| -13% | -$7.09M | 1.36% | 22 |
|
|
2016
Q1 | $46.5M | Sell |
527,070
-83,580
| -14% | -$7.37M | 1.39% | 25 |
|
|
2015
Q4 | $48.2M | Buy |
610,650
+363,010
| +147% | +$28.7M | 1.43% | 18 |
|
|
2015
Q3 | $35.2M | Sell |
247,640
-21,600
| -8% | -$3.07M | 1.34% | 16 |
|
|
2015
Q2 | $38.3M | Buy |
269,240
+150
| +0.1% | +$21.4K | 1.29% | 19 |
|
|
2015
Q1 | $38.3M | Hold |
269,090
| – | – | 1.28% | 19 |
|
|
2014
Q4 | $34.3M | Sell |
269,090
-93,370
| -26% | -$11.9M | 1.2% | 20 |
|
|
2014
Q3 | $37M | Buy |
362,460
+2,160
| +0.6% | +$221K | 1.37% | 12 |
|
|
2014
Q2 | $30.9M | Buy |
+360,300
| New | +$30.9M | 1.14% | 17 |
|